The short version of angiotensin IV fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-08-29 and is reviewed periodically as new material appears.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Interest in the collective's work gave rise to an artistic movement referred to as the Rogue Taxidermy art movement, or alternately, the Taxidermy Art movement. Apart from describing a genre of fine art, the term "rogue taxidermy" has expanded in recent years and has also become an adjective applied to unorthodox forms of traditional taxidermy such as anthropomorphic mounts and composite mounts where two or more animals are spliced together. (e.g.; sideshow gaffs of conjoined "freak" animals and mounts of jackalopes or other fictional creatures) In addition to being the impetus for the art movement, the inception of the genre also marked a resurgence of interest in conventional (traditional) forms of taxidermy.
Along with pancuronium bromide and potassium chloride, thiopental is used in 34 US states to execute prisoners by lethal injection. A large dose is given to ensure rapid loss of consciousness. Although death usually occurs within ten minutes of the beginning of the injection process, some have been known to take longer. In December 2009, Ohio became the first state in the US to use a single dose of sodium thiopental for an execution, following the failed use of the standard three-drug cocktail during a prior execution, due to inability to locate suitable veins. Kenneth Biros was executed using the single-drug method. Washington became the second state in the US to use the single-dose sodium thiopental injections for executions. In September 2010, the execution of Cal Coburn Brown was the first in the state to use a single-dose, single-drug injection. His death was pronounced approximately one and a half minutes after the intravenous administration of five grams of the drug. After its use for the execution of Jeffrey Landrigan in the US, the United Kingdom introduced a ban on the export of sodium thiopental in December 2010, after it was established that no European supplies to the US were being used for any other purpose. The restrictions were based on "the European Union Torture Regulation (including licensing of drugs used in execution by lethal injection)".
Cale Hooker (born 13 October 1988) is a former professional Australian rules footballer, who played for the Essendon Football Club in the Australian Football League (AFL). Hooker graduated from Applecross Senior High School and played for East Fremantle in the WAFL. Hooker was drafted by the Essendon Football Club with pick 54 in the 2007 national draft and made his debut against the Western Bulldogs in round 21, 2008. In 2009 and 2010 Hooker established himself as one of the club's key-position defenders. In 2011 Hooker made a good start to the season but tore a hamstring in round 13 and played only one further game for the season. During the trade period after the 2012 season Essendon contemplated trading Hooker to the West Coast Eagles. However, Hooker, who had a year to run on his contract, declined to be traded. In 2014 Hooker was Essendon's most reliable backman, coming second in the W.S. Crichton Medal and winning All-Australian selection for the first time. In 2015 Hooker was elevated to Essendon's Leadership Group. He started the year in defence but was switched to the forward line halfway through the season. He became a useful goal scorer and finished the season with 21 goals. He was awarded the W. S. Crichton Medal as Essendon's best and fairest. Hooker is noted for his marking ability and took in excess of 150 marks in each of 2013, 2014 and 2015. Hooker, along with 33 other Essendon players, was found guilty of using a banned performance-enhancing substance, thymosin beta-4, as part of Essendon's sports supplements program during the 2012 season.
The reality is that present computational methods are imperfect and provide, at best, only qualitatively accurate estimates of affinity. In practice, it requires several iterations of design, synthesis, and testing before an optimal drug is discovered. Computational methods have accelerated discovery by reducing the number of iterations required and have often provided novel structures. Computer-aided drug design may be used at any of the following stages of drug discovery:
Sources: en.wikipedia.org
== Notable people == Michael Dunn, Oscar- and Tony-nominated American actor, The Wild Wild West, Star Trek Warwick Davis, English actor and TV presenter, Willow, Return of the Jedi, Leprechaun film series. His two children also have SED. Lenny Rush, English actor, Am I Being Unreasonable? Natalia Grace, Ukrainian-born American with dwarfism, The Curious Case of Natalia Grace Alexander Katan, Dutch Jewish accountant, teacher, and translator who was murdered by the Nazis during the Holocaust, photos of him were notoriously on display in various museums.
==== Print media ==== While in Wisconsin covering the primary campaign for the United States presidential election of 1972, gonzo journalist Hunter S. Thompson submitted a satirical article to Rolling Stone accusing Democratic Party candidate Edmund Muskie of being addicted to ibogaine. Many readers, and even other journalists, did not realize that the Rolling Stone piece was facetious. The completely unfounded ibogaine assertion did significant damage to Muskie's reputation, and was cited as a factor in his loss of the nomination to George McGovern. Thompson later said he was surprised that anyone believed it. The article is included in Thompson's post-election anthology, Fear and Loathing on the Campaign Trail '72 (1973). Author and Yippie Dana Beal co-wrote the 1997 book The Ibogaine Story. American author Daniel Pinchbeck wrote about his own experience of ibogaine in his book Breaking Open the Head (2002), and in a 2003 article for The Guardian titled "Ten years of therapy in one night". Author and musician Geoff Rickly based his debut novel Someone Who Isn't Me on his real-life experiences with heroin addiction and an ibogaine clinic in Mexico. American investigative journalist, Rachel Nuwer, published a comprehensive feature for Reason magazine titled Can This Psychedelic Help Cure Opioid Addiction? In the article, Rachel speaks with experts in the field of opioid use disorder (OUD) and how ibogaine shows promising results for effective treatment and recovery. This is particularly true for those patients who also suffer from traumatic brain injuries (TBI).
=== Diet supplement === Donkey's milk is recommended for countering stomach acid, promoting the growth of intestinal flora, calming coughs and pertussis (a.k.a. whooping cough), and for use in the treatment of immune-mediated disorders.
An independence, considered imposed (favoring the historiographical thesis of independence granted, and not achieved or conceived) and very probably against the will of the Peruvians (from which previous declarations of independence would have already emerged, such as the Cuzco Rebellion, later repressed by the Peruvians themselves loyal to the Viceroyalty, and without the need for the intervention of an invading army), based on some phrases such as:
Because of an abnormal peripheral blood profile, the response to inflammatory skin conditions in patients with myelomonocytic leukemia can have the appearance of atypical cells at sites of inflammation, confusing the Mohs surgeon. Perineural spread, and benign changes simulating perineural spread. Tumor spreading along a nerve can be difficult to visualize, and sometime benign plasma cells can surround the nerve, simulating cancer. Anatomical area that is difficult to cut and process. Examples would be the ear, and other three-dimensional structures like eyelids. The ability to make a scallop-shaped incision is increasingly difficult when the surgical surface is no longer a flat plane, but is a three-dimensional, rigid structure. Recurrent skin cancer with multiple islands of recurrence. This can occur with either previous excision or after electrodesiccation and curettage. As these residual skin cancers are often bound in scar tissue and present in multiple locations in the scar of the previous surgical defect, they are no longer contiguous in nature. Some surgeons advocate the removal of the complete scar in the treatment of "recurrent" skin cancers. Others advocate removing only the island of local recurrence and leaving the previous surgical scar behind. The decision is often made depending on the location of the tumor and the goal of the patient and physician. Unreported or underreported recurrence. Many patients do not return to the original surgeon to report a recurrence.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
The lyophilized powder is commonly kept at -20 °C or lower, protected from moisture and light. Solutions may require colder storage and should avoid repeated freeze-thaw cycles. General peptide stability practices apply.